YARROW BIOSCIENCE, INC. Accumulated Other Comprehensive Income
YARROW BIOSCIENCE, INC. (YARW) had Accumulated Other Comprehensive Income of $0 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.00K.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $0.00 S-4/A · filed 2026-06-03 | |
| 2025-12-31 | $2.00K 10-Q · filed 2026-08-13 | |
| 2025-06-30 | -$2.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $20.00K S-4/A · filed 2026-06-03 | |
| 2024-09-30 | $34.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$58.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$70.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $26.00K 10-K · filed 2025-03-06 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-01 | |
| 2021-12-31 | $0.00 10-K · filed 2022-03-17 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-17 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$40.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $5.00K 10-K · filed 2021-03-04 | $24.00K 10-K · filed 2020-03-03 |
| 2019-09-30 | $35.00K 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $5.00K 10-Q · filed 2019-08-01 | |
| 2019-03-31 | -$10.00K 10-Q · filed 2019-05-02 | |
| 2018-12-31 | -$96.00K 10-K · filed 2020-03-03 | |
| 2018-09-30 | -$101.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | -$150.00K 10-Q · filed 2018-08-01 | |
| 2018-03-31 | -$202.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | -$51.00K 10-K · filed 2019-02-28 | |
| 2016-12-31 | -$26.00K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |